Non-melanoma skin cancers are the most common cancers in the U.S. and their incidence is increasing. Electrical impedance dermography (EID) is a newer non-invasive, quantitative and objective tool sensitive to detect alterations in the electrical properties of skin cancers. The overarching hypothesis of this proposal is that EID can be used to distinguish cancer subtypes that cannot be appreciated clinically.
